By GREGORY ZELLER // Broad Hollow Bioscience Park’s new head honcho is an old friend of regional commercialization. Dan Polner, most recently the incubator advocate for Stony Brook University’s Office…
Setting the mood: This month flew by, dear readers – yet it’s still April out there, at least for one more blustery day. It is Friday, however, and both…
By GREGORY ZELLER // Farmingdale pharmaceutical firm DepYmed is no stranger to capital investments – but a new infusion might be enough to push the rare-disease innovator over the commercialization…
Well, that was quick: Whether you vacationed the first or second half of the week, or merely slept in on Wednesday’s national holiday, here we are, dear readers – the…
A Long Island-born investment fund with a taste for tech has acquired an award-winning Manhattan-based digital health platform. Topspin Partners, formerly headquartered in Roslyn Heights and now based in Mamaroneck,…
By GREGORY ZELLER // These boots are made for talking – and now, several enterprising innovators have a firmer grasp on what to say, and how to say it, when…
By GREGORY ZELLER // A cutting-edge Long Island biotech with a unique cancer-fighting platform has closed a critical $2 million funding round. DepYmed Inc., spun out of Cold Spring Harbor…
By GREGORY ZELLER // It’s become vogue for research institutions to staff “entrepreneurs-in-residence,” experienced innovators who can help science-based startups find their commercial footing, because they’ve been there and done…
By Gregory Zeller // A Cold Spring Harbor biotech startup is the 10th and final recipient in the first co-funding round backed by Accelerate Long Island and the Long Island…
A joint venture between biotech stalwart Ohr Pharmaceutical and Cold Spring Harbor Laboratory is taking the fight to breast cancer – though a revolutionary treatment may still be a half-decade…